Differential expression between the three clusters (Fig. 3C) identified high expression of TUBA1B in cluster 5, which is associated with poor prognosis in NSCLC, suggesting persisting drug tolerance after the holiday period. The gene discussed is TUBA1B; the disease is non-small cell lung carcinoma.